S.M. Hahn - Concepedia

Author

S.M. Hahn

University of Pennsylvania

Also Known As

H Kang, Hahn S., S HAHN, S Hahn, S M Hahn, S. Hahn, S. M. Hahn, S.M. Hahn, Shannon W. Hahn, Shelly Hahn

113

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania Radiation Oncology Associates The University of Texas MD Anderson Cancer Center National Cancer Institute National Institutes of Health

About

S.M. Hahn is an author at University of Pennsylvania specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	754
2	Health Sciences	5	5	279
3	Biochemistry	2	2	231
4	Engineering	1	1	161
5	Biomedical Engineering	1	1	161

S.M. Hahn

Publications

974

Citations

H-Index

Page 1

	Year	Citations
Tempol, a stable free radical, is a novel murine radiation protector. S.M. Hahn, Zelig Tochner, C. Murali Krishna, PubMed Radiation EffectRadiation ExposureStable Free RadicalRadiation BiologyRedox Biology	1992	212
In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model. Periannan Kuppusamy, Mobae Afeworki, Ravi Shankar, PubMed EngineeringOncologic ImagingMagnetic ResonanceBiomedical EngineeringRedox Biology	1998	161
Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage. A. Samuni, Dorit Winkelsberg, A. Pinson, Journal of Clinical Investigation BiochemistryReactive Nitrogen SpecieMedicineLipid PeroxidationPhysiology	1991	146
Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancer Kevin Du, Rosemarie Mick, Theresa M. Busch, Lasers in Surgery and Medicine	2006	102
Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity. J. Liebmann, S.M. Hahn, John Cook, PubMed Chemoprevention StrategyCell CycleMetronomic ChemotherapyTumor BiologyToxicological Mechanism	1993	85
Pharmacokinetics of EF5 [2-(2-nitro-1- H -imidazol-1-yl)- N -(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles C. J. Koch, S.M. Hahn, K. Rockwell, Cancer Chemotherapy and Pharmacology Hypoxia MeasurementsPharmacological Study2-Nitro-1- H -Imidazol-1-ylMedicineHypoxia (Medicine)	2001	66
Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer. Laurie L. Herscher, S.M. Hahn, Glenn S. Kroog, Journal of Clinical Oncology	1998	41
Proton pencil beam scanning for mediastinal lymphoma: the impact of interplay between target motion and beam scanning Chuan Zeng, John P. Plastaras, Zelig Tochner, Physics in Medicine and Biology	2015	30
Vascularity and uptake of photosensitizer in small human tumor nodules: implications for intraperitoneal photodynamic therapy. C. Menon, S N Kutney, Shannon C. Lehr, PubMed	2001	27
Phase 2 5-Arm Trial of Ipilimumab Plus Lung or Liver Stereotactic Radiation for Patients with Advanced Malignancies James W. Welsh, Chad Tang, Patricia M. de Groot, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineOncology5-Arm TrialRadiation TherapyIpilimumab Plus Lung	2017	23

Page 1